Kestra Medical insider plans sale of 51,900 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kestra Medical Technologies, Ltd. reports a planned sale of up to 51,900 common shares through Merrill Lynch on NASDAQ, with an aggregate value of $1,272,585.45. The shares relate to a 07/17/2026 performance stock issuance granted under an equity compensation plan and follow multiple prior common share sales over recent months.
Key Figures
Key Terms
Performance Stock Issuance financial
equity compensation plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Kestra Medical Technologies (KMTS) disclose in this Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.